Crossmark

The mechanism of MMP14-positive tumor-associated fibroblast subsets in inhibiting PD-1 immunotherapy for esophageal cancer through exosomal tsRNA-10522

Crossref DOI link: https://doi.org/10.1007/s10142-024-01447-3

Published Online: 2024-10-08

Published Print: 2024-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Juzheng

Zheng, Chunlong

Lu, Jiayu

Xu, Xinyao

Xiang, Guangyu

Li, Jiahe

Zhang, Jipeng

Mu, Xiaorong

Lu, Qiang
Funding

Funding for this research was provided by:

National Outstanding Youth Science Fund Project of National Natural Science Foundation of China (82002422)
License Information

Text and Data Mining valid from 2024-10-01

Version of Record valid from 2024-10-08
More Information

Article History

Received: 28 June 2024

Revised: 4 September 2024

Accepted: 5 September 2024

First Online: 8 October 2024

Declarations

:

: All subjects participating in this study were fully informed about the purpose, process, potential risks and benefits of the study and voluntarily signed a written informed consent form.

: This study was approved by the Medical Ethics Committee of TangDu Hospital of the Fourth Military Medical University (ID:202101-23).

: The authors declare no competing interests.

Document is current

Any future updates will be listed below